Oragenics, Inc.
OGEN
$0.86
$0.000.43%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.97% | -2.48% | 33.80% | -35.98% | -6.85% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -100.00% | 199.95% | -- | -- | -- |
| Total Other Non-Cash Items | -9.09% | 109.59% | -219.24% | -82.56% | 468.38% |
| Change in Net Operating Assets | -79.60% | 2,040.10% | -101.51% | 686.84% | -76.96% |
| Cash from Operations | -127.06% | 37.77% | -4.64% | -2.44% | -27.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -2,155.64% | 32.00% | 25.57% | -123.47% | 7.26% |
| Issuance of Common Stock | -- | -100.00% | 131,665.00% | -99.95% | 309.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9,434.21% | -102.85% | 1,889.31% | -106.93% | 358.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 751.56% | -156.62% | 212.15% | -226.95% | 348.19% |